Search results for "RADIOTHERAPY"

showing 10 items of 473 documents

Brachytherapy organ dose estimation using Monte Carlo simulations of realistic patient models

2018

Radiation Therapy Planning Systems (RTPS) currently used in hospitals contain algorithms based on deterministic simplifications that do not properly consider electrons lateral transport in the areas where there are changes of density, and as a result, erroneous dose predictions could be produced. According to this, the present work proposes the use of Monte Carlo method in brachytherapy planning systems, which could affect positively on the radiotherapy treatment planning, since it provides results that are more accurate and takes into account the in homogeneities density variations. This paper presents a Monte Carlo (MC) simulation of a brachytherapy prostate treatment with I-125 seeds, us…

Malemedicine.diagnostic_testComputer scienceRadiotherapy Planning Computer-Assistedmedicine.medical_treatmentBrachytherapyMonte Carlo methodBrachytherapyRadiotherapy DosageComputed tomographyRadiotherapy treatment planningBrachytherapy prostateIodine RadioisotopesDose estimationmedicineHumansSegmentationRadiation treatment planningMonte Carlo MethodAlgorithmAlgorithms2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
researchProduct

Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancer.

2001

Background Radiotherapy of the head region in children is known to cause long-term sequelae, such as facial, dental, and ocular abnormalities. We investigated whether a decreased nasal mucociliary function occurs after radiotherapy of the head in children. Methods A saccharin/charcoal test was performed in 20 children treated with radiotherapy of the head and in 20 controls, age-matched and gender-matched. Results We found a decreased nasal mucociliary clearance (lower percentage of responses (p = 0083) and longer mucociliary transport times (p = .0001) in the patients compared with the controls. The radiotherapy dosage influenced the response to the test (p = .0046). Conclusions Irradiatio…

Malemedicine.medical_specialtyAdolescentMucociliary clearancemedicine.medical_treatmentMucous membrane of noseSaccharinEosinophiliaMedicineEosinophiliaHumansChildRadiation InjuriesRespiratory Tract InfectionsNoseAdministration IntranasalRespiratory tract infectionsRadiotherapybusiness.industryDose-Response Relationship RadiationSurgeryRadiation therapyNasal Mucosamedicine.anatomical_structureOtorhinolaryngologyEpidermoid carcinomaHead and Neck NeoplasmsMucociliary ClearanceAnesthesiaCase-Control StudiesCharcoalChild PreschoolChronic DiseaseFemalemedicine.symptombusinessComplicationHeadneck
researchProduct

Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for…

2019

Objective. The purpose of this study was to investigate whether, compared with traditional criteria, the modified Response Evaluation Criteria in Solid Tumors version 1.1 for immune-based therapeutics (iRECIST) improves prediction of local tumor control and survival in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT). Materials and Methods. Fifty-one HCC lesions (mean size, 3.1 cm) treated with SBRT in 41 patients (mean age, 67 years) were retrospectively included. Each patient underwent CT or MRI before SBRT and at least once after SBRT. Best overall response was categorized using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIS…

Malemedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinomamedicine.medical_treatmentContrast MediaRadiosurgeryRadiosurgerySurvival analysiMcNemar's testRetrospective StudieResponse Evaluation Criteria in Solid Tumors (RECIST)Local recurrenceTargeted radiotherapymedicineHumansRadiology Nuclear Medicine and imagingSurvival rateResponse Evaluation Criteria in Solid TumorsSurvival analysisRetrospective StudiesAgedAged 80 and overbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseSurvival RateExact testTreatment OutcomeLiver NeoplasmResponse Evaluation Criteria in Solid TumorsHepatocellular carcinomaFemaleRadiologybusinessProgressive diseaseHumanAmerican Journal of Roentgenology
researchProduct

Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer: an assessment

2014

Background This study is conducted mainly to evaluate the changes in quality and quantity of oral epithelial cells during the course of IMRT. Material and Methods 30 Patients undergoing chemo-radiotherapy were followed through course of treatment. They were compared with a group of age- and sex-matched healthy individuals. The procedure involved WHO clinical scoring, collection of oral washings and preparation of buccal smears from both study group and control group. The changes occurred were recorded as a way of assessing the severity of oral mucositis. Results Revealed a significant occurrence of oral mucositis in almost all patients during weekly follow up. There was a significant increa…

Malemedicine.medical_specialtyCell SurvivalMucosal cellAntineoplastic AgentsOdontologíaCellular levelGastroenterologyInternal medicinemedicineMucositisHumansGeneral DentistryStomatitisChemo-radiotherapyStomatitisOral Medicine and Pathologybusiness.industryResearchHead and neck cancerEpithelial CellsBuccal administrationmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyHead and Neck NeoplasmsHealthy individualsUNESCO::CIENCIAS MÉDICASSurgeryFemaleRadiotherapy Intensity-Modulatedbusiness
researchProduct

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological …

2013

Background: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. Aim: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. Methods: A cohort of 151 consecutive patients with early stage HCC (122 Child-Pugh class A and 29 class B patients) treated with RFA were enrolled. Clinical, laboratory and radiological follow-up data were collected from the time of first RFA. A single lesion was observed in 113/151 (74.8%), two lesions in 32/151 (21.2%), and three lesions in 6/151 (4%) of patients. Results: The overall survival rates …

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma HepatocellularClinical Research Designmedicine.medical_treatmentCancer Treatmentlcsh:MedicineCatheter ablationGastroenterology and HepatologyGastroenterologyCohort StudiesInternal medicineGastrointestinal CancersGastrointestinal TumorsmedicineHumansStage (cooking)lcsh:ScienceAgedMultidisciplinaryRadiotherapybusiness.industryLiver Diseaseslcsh:RLiver NeoplasmsCancers and NeoplasmsHepatocellular CarcinomaMiddle Agedmedicine.diseaseAblationFibrosisdigestive system diseasessurgical procedures operativeTreatment OutcomeCirrhosisOncologyRadiological weaponHepatocellular carcinomaCatheter AblationMedicineHepatocellular carcinoma survival RFAlcsh:QFemalebusinessLiver cancerResearch ArticlePloS one
researchProduct

Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.

2015

The implementation of preoperative chemoradiation combined with total mesorectal excision has reduced local recurrence rates in rectal cancer. However, the use of both types of treatment in upper rectal cancer is controversial.The purpose of this work was to assess oncological results after radical resection of upper rectal cancers compared with sigmoid, middle, and lower rectal cancers and to determine risk factors for local recurrence in upper rectal cancer.This was a retrospective analysis of prospectively collected data.This study was conducted in a tertiary care referral hospital in Valencia, Spain.Analysis included 1145 patients who underwent colorectal resection with primary curative…

Malemedicine.medical_specialtyColorectal cancerUnnecessary ProceduresPreoperative careDisease-Free SurvivalRisk FactorsPreoperative CareMedicineHumansSurvival rateAgedNeoplasm StagingRetrospective StudiesPreoperative chemoradiotherapybusiness.industryRectal NeoplasmsGastroenterologyFollow up studiesRetrospective cohort studyGeneral MedicineChemoradiotherapy Adjuvantmedicine.diseasePrognosisTotal mesorectal excisionMagnetic Resonance ImagingSurvival RateSigmoid NeoplasmsTreatment OutcomeFemaleRadiologyNeoplasm Recurrence LocalbusinessChemoradiotherapyFollow-Up StudiesDiseases of the colon and rectum
researchProduct

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy

2005

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy. Cordova A, Corradino B, Pirrello R, Di Lorenzo S, Dispenza C, Moschella F. Source Dipratimento di Discipline Chirurgiche ed Oncologiche, Divisione di Chirurgia Plastica e Ricostruttiva, Facolta di Medicina, Universita di Palermo, Palermo, Italy. chirplas@unipa.it Abstract CONCLUSION: Our experience confirms that pectoralis major flap is the first-choice technique for repairing recurrent hypopharyngeal fistulae in previously irradiated patients in whom microsurgical techniques are not indicated, and that hyperbaric oxygen therapy helps to solv…

Malemedicine.medical_specialtyCutaneous FistulaFistulamedicine.medical_treatmentLaryngectomyHyperbaric oxygen therapy hypopharyngeal fistula pectoralis major flap pharyngolaryngeal carcinoma pharyngolaryngeal reconstruction pharyngostomeSurgical FlapsPectoralis MusclesPostoperative ComplicationsCarcinomamedicineHumansSurgical FlapsPectoralis MuscleLaryngeal NeoplasmsAgedAged 80 and overHyperbaric Oxygenationbusiness.industryPectoralis major musclePharyngeal NeoplasmsPharyngeal DiseasesGeneral MedicineMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurgeryLaryngectomyTreatment OutcomePharyngeal NeoplasmOtorhinolaryngologyFemaleRadiotherapy AdjuvantComplicationbusiness
researchProduct

Bowel perforation after pneumatic dilatation: Management with fully covered self-expandable metallic stent.

2019

Malemedicine.medical_specialtyHepatologybusiness.industryColonForeign-Body MigrationGastroenterologySelf Expandable Metallic StentsProstatic NeoplasmsBowel perforationConstriction PathologicAdenocarcinomaDilatationSurgeryColonic DiseasesForeign-Body MigrationSelf-expandable metallic stentIntestinal PerforationmedicineHumansRadiotherapy AdjuvantbusinessRadiation InjuriesIntestinal ObstructionAgedGastroenterologia y hepatologia
researchProduct

What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort

2021

International audience; Introduction: for localized T1N0 squamous cell carcinoma of the anus (SCCA) standard radiotherapy (RT) may result in overtreatment and alternative strategies are debated. Methods: T1N0M0 SCCA treated between 2015 and 2020 by local excision (LE) or RT were analyzed from the French prospective FFCD ANABASE cohort. Treatment strategies, recurrence-free and colostomy-free survivals (RFS, CFS) and prognostic factors were reported. Results: among 1135 SCCA patients, 99 T1N0M0 were treated by LE(n = 17,17.2%), or RT ( n = 82,82.8%) including RT alone ( n = 65,79.2%) or chemo-RT ( n = 17, 20.7%). Median follow-up was 27.2 months [0.03 and ndash;54.44]. Median tumor size were…

Malemedicine.medical_specialtyLocal excisionLocal excisionmedicine.medical_treatmentAnal Canal[SDV.CAN]Life Sciences [q-bio]/CancerGastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overUnivariate analysisHepatologyRadiotherapybusiness.industryOptimal treatmentGastroenterologyAnal Squamous Cell CarcinomaChemoradiotherapyMiddle AgedAnusAnus Neoplasms3. Good healthRadiation therapymedicine.anatomical_structureAnal canal carcinoma030220 oncology & carcinogenesisCohortCarcinoma Squamous CellFemaleFrancebusinessChemoradiotherapy
researchProduct

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Resul…

2018

Abstract Background and purpose Standard treatment of epidermoid anal cancer is 5-fluorouracil (5FU) and mitomycin C (MMC) based chemoradiotherapy (CRT). This phase I study aims to evaluate the addition of panitumumab (Pmab) to CRT and to determine the maximum tolerated dose (MTD) of Pmab and 5-FU in combination with CRT. Materials and methods Immunocompetent patients with locally advanced tumour without metastases (Stage T2, T3 or T4, whatever N stage; Stage N1–N3 whatever T stage) followed two RT periods (45 Gy in 5 weeks and 20 Gy in 2 weeks, separated by a 2-week break) with concomitant CT sessions of 5FU/MMC at RT weeks 1, 5 and 8. Pmab was administered on RT weeks 1, 3, 5, 8 and 10 ac…

Malemedicine.medical_specialtyMitomycinUrologyPhases of clinical research030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAnal cancerPanitumumabRadiology Nuclear Medicine and imagingProspective StudiesAgedbusiness.industryPanitumumabStandard treatmentMitomycin CChemoradiotherapyHematologyMiddle AgedAnus Neoplasmsmedicine.diseaseErbB ReceptorsOncology030220 oncology & carcinogenesisConcomitantT-stageFemaleFluorouracilbusinessChemoradiotherapymedicine.drugRadiotherapy and Oncology
researchProduct